Financhill
Back

SPDR Bloomberg 1-3 Month T-Bill ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
10

BIL
SPDR Bloomberg 1-3 Month T-Bill ETF

Last Price:
$91.54
Seasonality Move:
-0.01%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Sell
10
SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) is a Sell

Is SPDR Bloomberg 1-3 Month T-Bill ETF a Buy, Sell or Hold?

  • The current SPDR Bloomberg 1-3 Month T-Bill ETF [BIL] share price is $91.53. The Score for BIL is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • BIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIL Stock Price Chart

What is SPDR Bloomberg 1-3 Month T-Bill ETF's stock price today?

  • The SPDR Bloomberg 1-3 Month T-Bill ETF share price today is $91.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 45.95 Sell
Chaikin Money Flow: 19064530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.47 - 91.65) Sell
Bollinger Bands (100): (91.48 - 91.7) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

BIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.54 Sell
20-day SMA: 91.57 Sell
50-day SMA: 91.55 Sell
200-day SMA: 91.61 Sell
8-day EMA: 91.53 Buy
20-day EMA: 91.56 Sell
50-day EMA: 91.57 Sell
200-day EMA: 91.59 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

SPDR Bloomberg 1-3 Month T-Bill ETF Earnings Growth & BIL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

SPDR Bloomberg 1-3 Month T-Bill ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):